Provincial Cerebral Palsy Associations, researchers and committed stakeholders are partnering to enhance the health and well-being of children, youth and adults
A breakthrough discovery made by doctors at the Montreal Children's Hospital about the causes of certain forms of Cerebral Palsy (CP) is giving new hope to one West Island family. https://t.co/mvBSG8a66W
CP-NET is hosting a webinar on the New International Clinical Practice Guideline/AACPDM Care Pathway for Dystonia in Cerebral Palsy.
Register here: https://t.co/IRLP6nmxxs
This online event will bring together the insights of a clinical researcher and both current and future parents with CP from different parts of the world. https://t.co/VN5Tl1tNLw
“Society isn’t set up for other abilities.” 🌷👉 Meet this week’s Lived & Living Experience Leader, Gillian Backlin, a Public Health student and enthusiastic member of the NYAC living with #CerebralPalsy: https://t.co/Yr5diopzFl
This research project is exploring how youth with acquired brain injuries (ABI) use digital communication like social media, gaming, and texting.
https://t.co/yHzOqzkaj1
This study uses virtual body-map storytelling methods to learn about how children labelled physically disabled (age 6-13) think and feel about their experiences living with chronic pain.
Cerebral palsy is a group of neurological disorders that affect movement, muscle tone, and coordination. The energy expenditure can vary significantly among people with CP due to factors such as the extent of motor impairment, muscle spasticity, presence of associated conditions.
We hosted a press conference with @YourAlberta and @KidSportAlberta at our Calgary headquarters today. Get out your shades! The future of kids' sports and recreational programming is looking bright. See the press conference here: https://t.co/MNVxaSi10G
It is Cerebral Palsy Awareness Month!
This event will present the Global Report on Children with Developmental Disabilities published by WHO and UNICEF in September 2023, and its key findings for CP.
To register, click here: https://t.co/QOl2YdpFcI #CerebralPalsy
"...we developed a self-assembled, peptide system that could carry dexamethasone (a corticosteroid) to the site of injury in the brain," https://t.co/lTyh4qW5UU
N eurotech International has received approval from the Human Research Ethics Committee (HREC) and clearance from the Therapeutic Goods Administration (TGA) to begin a Phase I/II clinical trial of NTI164 for the treatment of cerebral palsy (CP).
https://t.co/KMrshNP7ZC